$6.32-0.39 (-5.81%)
AXIL Brands, Inc.
AXIL Brands, Inc. in the Technology sector is trading at $6.32 with a market capitalization of $48M. Wall Street consensus targets $14.25 (1 analysts), implying a +125.5% move over the next 12 months. The stock is currently 38% below its 52-week high of $10.25, remaining 2.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
AXIL Brands, Inc. engages in the manufacture, marketing, distribution, and sale of hearing and audio enhancement and protection products in the United States, Canada, Europe, Australia, New Zealand, Africa, and Asia. The company operates through Hear...
In recent months, partner brands including Buda Juice, Every Man Jack, Axil Brands, and Rogue have announced expanded product distribution or exclusive launches at Walmart stores and online, while Walmart itself opened a US$350.00 million, 300,000-square-foot milk processing facility in Robinson, Texas to supply more than 650 locations across the South Central U.S. and deepen control of its dairy supply chain. Together with Walmart’s ongoing investments in AI-enabled automation, fintech...
Walmart is expanding distribution for several third party brands, including Buda Juice, Axil Brands, Rogue snacks, and O Positiv Health, across its U.S. stores. The rollouts focus on wellness, nutrition, women's health, and sporting goods, with some products launching on an exclusive basis at Walmart. This product push reflects a broader effort to widen Walmart's in store assortment in categories that can attract new shoppers and repeat visits. For investors tracking NasdaqGS:WMT, this...
AXIL Brands reports higher y/y revenues in Q3 but earnings fall as rising costs and marketing investments pressure margins amid ongoing retail expansion efforts.
NVDA, AMZN and REGN headline Zacks' top stock reports, spotlighting AI growth, cloud momentum and oncology pipeline strength.
NVDA headlines Zacks Research Daily as AI-driven data center growth powers outlook, while Amazon and Regeneron show mixed but resilient trends.